MUSKOMED capsules 4 mg
Back to ProductsPrescription drug. A muscle relaxant with a central mechanism of action.
Capsules
Articles
- The combination of thiocolchicoside and dexketoprofen as therapy of choice for myofascial pain syndrome in the acute period Published in the journal «News of Medicine and Pharmacy» (598)’2016
- On the efficacy of the drug Muscomed in patients with post-stroke spasticity Published in a journal «International Neurological Journal» № 1 (87)’2017
- Muscomed in the treatment of patients with dorsalgia Published in a journal «Neurology and Neurosurgery. Eastern Europe» Vol 8 №3 ’2018
- Modern approaches to the treatment of spasticity: which muscle relaxant to choose?
- We unite for the sake of Victory with the charitable fund «Help UA» Charitable Foundation «Help UA» june’2023
- We unite for the sake of Victory with the KNP ISR «Ivankivska CDH» «Ivankivska CDH» june’2023
- Differential diagnosis of headache Published in a journal «International Journal of Neurology» Vol 16 № 5’2020
- Evidence-Based Medicine for lower back pain Published in a journal «International Neurological Journal» Vol 16 № 3 ’2020
- Tension headache and cervicogenic headache: features of the clinical picture, diagnosis and treatment tactics Published in a journal «International Neurological Journal» № 3 (105) ’2019
- Modern aspects of providing care for the consequences of traumatic brain injury and back pain Published in a journal «International Neurological Journal» № 8 (86) ’2016
- Pathogenetic and therapeutic aspects of using the drug Muscomed for vertebrogenic muscular-tonic syndromes Published in a journal «International Neurological Journal» № 5 (83) ’2016
SPC
MUSKOMED capsules 4 mg
SPC — PDF